Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 34:2002-2006
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woo, K. S.
Right arrow Articles by Celermajer, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woo, K. S.
Right arrow Articles by Celermajer, D. S.

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia

Kam S. Woo, MD, FRACP, FACC*, Ping Chook, MD*, Yvette I. Lolin, PhD{dagger}, John E. Sanderson, MD, FACC*, Con Metreweli, MD, FRCR{ddagger} and David S. Celermajer, PhD, FRACP§

* Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
{dagger} Department of Clinical Chemistry, Kent and Sussex Hospital, Kent, UK
{ddagger} Department of Diagnostic Radiology and Organ Imaging, The Chinese University of Hong Kong, Hong Kong
§ Department of Medicine, University of Sydney, Sydney, Australia



View larger version (15K):

[in a new window]
 
Figure 1 EDD at baseline and after eight weeks of therapy with either oral folic acid, 10 mg/day (left panel) or placebo (right panel). For each condition, the mean and SD for the group are presented.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement